APA (7th ed.) Citation

AE, T., MA, B., A, A., BM, A., LH, B., E, C., . . . AW, H. (2018). Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia. Nature communications, 9(1), 5341. https://doi.org/10.1038/s41467-018-07551-w

Chicago Style (17th ed.) Citation

AE, Tron, et al. "Discovery of Mcl-1-specific Inhibitor AZD5991 and Preclinical Activity in Multiple Myeloma and Acute Myeloid Leukemia." Nature Communications 9, no. 1 (2018): 5341. https://doi.org/10.1038/s41467-018-07551-w.

MLA (9th ed.) Citation

AE, Tron, et al. "Discovery of Mcl-1-specific Inhibitor AZD5991 and Preclinical Activity in Multiple Myeloma and Acute Myeloid Leukemia." Nature Communications, vol. 9, no. 1, 2018, p. 5341, https://doi.org/10.1038/s41467-018-07551-w.